ABL1 and synucleinopathy: Overall, our results support the novel conclusion that α-synucleinopathy-dependent activation of c-Abl/p53 is a key underlying cause of autophagy deficit in α-synucleinopathy and that c-Abl/p53 activity is a significant target for therapeutic intervention in α-synucleinopathies.